These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9186444)

  • 1. Estimating progression of visual field loss in glaucoma.
    Katz J; Gilbert D; Quigley HA; Sommer A
    Ophthalmology; 1997 Jun; 104(6):1017-25. PubMed ID: 9186444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of progressive change in automated visual fields in glaucoma.
    Smith SD; Katz J; Quigley HA
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1419-28. PubMed ID: 8641844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of Glaucoma Hemifield Test Results and Visual Field Features in Glaucoma.
    Wang M; Pasquale LR; Shen LQ; Boland MV; Wellik SR; De Moraes CG; Myers JS; Wang H; Baniasadi N; Li D; Silva RNE; Bex PJ; Elze T
    Ophthalmology; 2018 Mar; 125(3):352-360. PubMed ID: 29103791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic disc progression and rates of visual field change in treated glaucoma.
    De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
    Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Visual Field Progression in Glaucoma Patients with Progressive Retinal Nerve Fiber Layer Thinning: A 5-Year Prospective Study.
    Yu M; Lin C; Weinreb RN; Lai G; Chiu V; Leung CK
    Ophthalmology; 2016 Jun; 123(6):1201-10. PubMed ID: 27001534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function evaluation (SAFE): I. criteria for glaucomatous visual field loss using standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP).
    Johnson CA; Sample PA; Cioffi GA; Liebmann JR; Weinreb RN
    Am J Ophthalmol; 2002 Aug; 134(2):177-85. PubMed ID: 12140023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cataract extraction on the results of automated perimetry in glaucoma.
    Smith SD; Katz J; Quigley HA
    Arch Ophthalmol; 1997 Dec; 115(12):1515-9. PubMed ID: 9400784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and spatial concordance of visual field deterioration in fellow eyes of glaucoma patients.
    Kim MK; Lee JM; Morales E; Caprioli J
    Korean J Ophthalmol; 2014 Dec; 28(6):436-43. PubMed ID: 25435745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misleading statistical calculations in far-advanced glaucomatous visual field loss.
    Blumenthal EZ; Sapir-Pichhadze R
    Ophthalmology; 2003 Jan; 110(1):196-200. PubMed ID: 12511366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology.
    Quigley HA
    Am J Ophthalmol; 1998 Jun; 125(6):819-29. PubMed ID: 9645719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression.
    de Moraes CG; Song C; Liebmann JM; Simonson JL; Furlanetto RL; Ritch R
    Ophthalmology; 2014 Mar; 121(3):741-9. PubMed ID: 24290806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.
    Boodhna T; Crabb DP
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):225-30. PubMed ID: 25545852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated perimetry detects visual field loss before manual Goldmann perimetry.
    Katz J; Tielsch JM; Quigley HA; Sommer A
    Ophthalmology; 1995 Jan; 102(1):21-6. PubMed ID: 7831036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).
    O'Leary N; Chauhan BC; Artes PH
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6776-84. PubMed ID: 22952123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.